Lv0
0 积分 2024-05-15 加入
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
4小时前
待确认
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation
1个月前
已完结
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
3个月前
已完结
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
3个月前
已完结
Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening
5个月前
已完结
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
5个月前
已完结
Breast cancer organoids derived from patients: A platform for tailored drug screening
6个月前
已完结
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy
9个月前
已完结
Progress and perspective of organoid technology in breast cancer research
10个月前
已完结
Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell
11个月前
已完结
皖公网安备34019202002308
